DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$5.67
+3.75%
Mkt Cap $303.90M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+47.0%
Consensus $8.33 vs current $5.67
NASDAQ·Healthcare·Biotechnology
$5.67
+3.75%
Mkt Cap $303.90M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+47.0%
Consensus $8.33 vs current $5.67